RA Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $351M | Sell |
|
|||||
|
2025
Q1 | $322M | Hold |
|
|||||
|
2024
Q4 | $341M | Hold |
|
|||||
|
2024
Q3 | $319M | Hold |
|
|||||
|
2024
Q2 | $250M | Buy |
|
|||||
|
2024
Q1 | $231M | Hold |
|
|||||
|
2023
Q4 | $245M | Sell |
|
|||||
|
2023
Q3 | $130M | Hold |
|
|||||
|
2023
Q2 | $93.6M | Buy |
|
|||||
|
2023
Q1 | $98.4M | Hold |
|
|||||
|
2022
Q4 | $161M | Buy |
|
|||||
|
2022
Q3 | $134M | Buy |
|
|||||
|
2022
Q2 | $20.2M | Hold |
|
|||||
|
2022
Q1 | $56.1M | Hold |
|
|||||
|
2021
Q4 | $48.6M | Hold |
|
|||||
|
2021
Q3 | $63.6M | Hold |
|
|||||
|
2021
Q2 | $71.1M | Hold |
|
|||||
|
2021
Q1 | $104M | Buy |
|
|||||
|
2020
Q4 | $124M | Sell |
|
|||||
|
2020
Q3 | $111M | Sell |
|
|||||
|
2020
Q2 | $116M | Sell |
|
|||||
|
2020
Q1 | $82.5M | Hold |
|
|||||
|
2019
Q4 | $124M | Buy |
|
|||||
|
2019
Q3 | $73.9M | Buy |
|
|||||
|
2019
Q2 | $41.5M | Hold |
|
|||||
|
2019
Q1 | $51.7M | Sell |
|
|||||
|
2018
Q4 | $52.4M | Hold |
|
|||||
|
2018
Q3 | $56.9M | Buy |
|
|||||
|
2018
Q2 | $48.2M | Buy |
|